Agenus reports mixed results from gastroesophageal cancer trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Agenus reports mixed results from gastroesophageal cancer trial
AGENUS (NASDAQ: AGEN) Delayed: 3.04 +0.04 (1.33%)
Previous Close $3.00    52 Week High $7.49 
Open $2.99    52 Week Low $2.61 
Day High $3.10    P/E N/A 
Day Low $2.98    EPS $-1.10 
Volume 475,961